Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
SURGICEL® Powder in Controlling Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding in Adult Subjects
ClinicalTrials.gov study NCT03762200. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study in Moderate to Severe Rheumatoid Arthritis
ClinicalTrials.gov study NCT01710358. IPD Sharing: YES. Countries: 28. Publications: 15.
A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
ClinicalTrials.gov study NCT02167139. IPD Sharing: NO. Countries: 2. Publications: 5.
Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03575871. IPD Sharing: YES. Countries: 13. Publications: 14.
GB001 in Adult Subjects With Moderate to Severe Asthma
ClinicalTrials.gov study NCT03683576. IPD Sharing: NO. Countries: 11. Publications: 2.
The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy Males
ClinicalTrials.gov study NCT04470908. IPD Sharing: YES. Countries: 1. Publications: 1.
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
ClinicalTrials.gov study NCT01313208. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT05335356. IPD Sharing: NO. Countries: 1. Publications: 2.
A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT03384745. IPD Sharing: Not stated. Countries: 7. Publications: 1.
A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness
ClinicalTrials.gov study NCT04427501. IPD Sharing: YES. Countries: 1. Publications: 11.
A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection
ClinicalTrials.gov study NCT04602000. IPD Sharing: NO. Countries: 1. Publications: 4.
Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder
ClinicalTrials.gov study NCT00621946. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT03467958. IPD Sharing: Not stated. Countries: 49. Publications: 1.
Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis
ClinicalTrials.gov study NCT02969018. IPD Sharing: YES. Countries: 3. Publications: 3.
A Study to Evaluate the Effects of BGF and GFF on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD
ClinicalTrials.gov study NCT03836677. IPD Sharing: Not stated. Countries: 2. Publications: 1.
An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease
ClinicalTrials.gov study NCT01009281. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT02531126. IPD Sharing: Not stated. Countries: 20. Publications: 6.
Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT02785185. IPD Sharing: YES. Countries: 1. Publications: 1.
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
ClinicalTrials.gov study NCT03526861. IPD Sharing: NO. Countries: 10. Publications: 4.
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03611751. IPD Sharing: Not stated. Countries: 16. Publications: 6.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.